Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

Share Price is delayed by 15 minutes
Get Live Data
590.00    11.00 (1.90%)
Bid:
589.00
Ask:
591.00
Spread: 2.00 (0.34%)
Market Cap: £857.80m
SAGA Live PriceLast checked at - London Stock Exchange

Intraday Saga Share Chart

Stabilisation Notice

23 May 2014 07:15

RNS Number : 8773H
BofA Merrill Lynch
23 May 2014
 



 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

Saga plc

Stabilisation Notice

 

Merrill Lynch International (contact: Daniel Norman; telephone: +44 (0) 20 995 3700) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

 

The securities:

Issuer:

Saga plc

Securities:

Ordinary Shares at a price of 1 pence each (ISIN - GB00BLT1Y088)

Offering Description:

Initial Public Offering of Ordinary Shares

Offering Size:

297,297,297 Ordinary Shares

Offer Price:

185 pence per Ordinary Share

Stabilisation:

Stabilisation Manager:

Merrill Lynch International

Stabilisation period expected to start on:

23 May 2014 at approximately 8.00am

Stabilisation period expected to end no later than:

21 June 2014 COB

Over-allotment Option:

Existence and conditions of use of over-allotment facility:

The Stabilisation Manager may over-allot the securities to the extent permitted in accordance with applicable law.

Maximum size of over-allotment facility

44,594,594 number of shares

 

In connection with the offer of the above securities, the Stabilisation Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAPGUAPAUPCPUP
Date   Source Headline
5th Jul 20224:19 pmRNSResult of 2022 AGM
5th Jul 20227:00 amRNSDirectorate Change
5th Jul 20227:00 amRNSTrading Update
30th May 20229:00 amRNSNotice of 2022 AGM
3rd May 20225:04 pmRNSDirector/PDMR Shareholding
31st Mar 20224:29 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSPreliminary Results
27th Jan 20227:00 amRNSTrading Update
1st Dec 20217:00 amRNSTotal Voting Rights
19th Nov 20214:54 pmRNSDirector/PDMR Shareholding
17th Nov 20217:00 amRNSDirector/PDMR Shareholding
12th Nov 20212:23 pmRNSIssue of Equity
22nd Sep 20217:00 amRNSInterim Results
20th Sep 202110:16 amRNSHolding(s) in Company
4th Aug 202112:13 pmRNSPost Stabilisation Notice
30th Jun 20218:00 amRNSFinal results of tender offer
25th Jun 20213:50 pmRNSPricing of fixed rate guaranteed bonds
25th Jun 202111:15 amRNSPre Stabilisation Notice
22nd Jun 20218:00 amRNSFinancing transactions
14th Jun 20213:14 pmRNSResult of AGM
14th Jun 20217:00 amRNSAGM Trading Update
14th May 20212:50 pmRNSDirector/PDMR Shareholding
11th May 20217:00 amRNSNotice of AGM
6th May 202111:22 amRNSDirector/PDMR Shareholding
30th Apr 20212:57 pmRNSDirector/PDMR Shareholding
15th Apr 202110:06 amRNSHolding(s) in Company
7th Apr 20217:00 amRNSPreliminary Results
16th Mar 202111:00 amRNSHolding(s) in Company
5th Mar 20217:00 amRNSCorporate and cruise ship finance facilities
8th Feb 20218:36 amRNSHolding(s) in Company
3rd Feb 20215:03 pmRNSHolding(s) in Company
26th Jan 20217:00 amRNSTrading Update
5th Jan 20217:00 amRNSDirectorate Change
18th Dec 20207:00 amRNSAppointment of Joint Corporate Brokers
3rd Dec 20202:23 pmRNSDirectorate Change
1st Dec 202011:24 amRNSHolding(s) in Company
30th Nov 20204:02 pmRNSTotal Voting Rights & Capital
27th Nov 20207:00 amRNSSaga awarded industry-leading accreditation
26th Nov 20204:42 pmRNSDirector/PDMR Shareholding
23rd Nov 20203:28 pmRNSHolding(s) in Company
18th Nov 202010:39 amRNSHolding(s) in Company
13th Nov 20207:00 amRNSIssue of Equity
2nd Nov 20204:07 pmRNSTotal Voting Rights & Capital
16th Oct 20207:00 amRNSDirector/PDMR Shareholding
9th Oct 20208:00 amRNSShare Consolidation
7th Oct 20205:13 pmRNSDirector/PDMR Shareholding
7th Oct 20205:09 pmRNSHolding(s) in Company
6th Oct 20204:30 pmRNSHolding(s) in Company
5th Oct 20205:16 pmRNSHolding(s) in Company
2nd Oct 20202:05 pmRNSResults of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.